Parametrica Management LTD Exelixis, Inc. Transaction History

Parametrica Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$17.44 - $23.16 $202,199 - $268,517	-11,594 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$17.03 - $22.67 $76,447 - $101,765	-4,489 Reduced 27.91%	11,594 $263,000
Q4 2021 Feb 15, 2022	BUY	$15.84 - $21.88 $254,754 - $351,896	16,083 New	16,083 $294,000
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $1.64 Million - $2.33 Million	-91,127 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$20.53 - $25.22 $1.87 Million - $2.3 Million	91,127 New	91,127 $2 Million

460

240M

2.04M

1.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.53B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.